Chartwell Enhances IV Preparations with Omnicell® IVX Workflow
PITTSBURGH--(BUSINESS WIRE)-- Chartwell Pennsylvania, LP, the nation’s leading health-system based provider of home infusion, specialty pharmacy, and enteral nutrition, has partnered with Omnicell to install their IVX Workflow sterile compounding technology to manage chemotherapy drug product preparations. A leading provider of medication management solutions and adherence tools for health systems and pharmacies, Omnicell’s IVX Workflow solution is designed to enhance safety, ensure dosing accuracy, and facilitate compliance, which will allow Chartwell to lead the way to zero-error medication management.
In December of 2020, Chartwell and UPMC announced a partnership with CarepathRx to expand patient access to innovative specialty pharmacy and home infusion services. “With a commitment to patient care, CarepathRx is proud to partner with Omnicell to become the first provider in the nation to implement the IVX Workflow technology in a home infusion application,” said David Benedict, PharmD, BCPS, Chief Operating Officer at CarepathRx Specialty Pharmacy and Infusion Solutions. “Developing new and innovative competencies with this type of technology further enhances CarepathRx’s leadership role in the health-system direct home infusion treatment space.”
The use of Omnicell’s IVX Workflow allows Chartwell technicians to implement a step-by-step preparation of chemotherapy that employs gravimetric verification and barcode-scanning. Computer processing through IVX Cloud administers orders from the clinical pharmacist directly to Chartwell’s state-of-the-art cleanrooms. Plans are currently underway to expand this application to all non-TPN products, including hazardous and non-hazardous home infusion therapies.
“In addition to barcode scanning and gravimetrics, Chartwell implemented automated photography to give our pharmacists the ability to review each step throughout the IV preparation,” said Kyra Wivagg, PharmD, Manager of Pharmacy Operations at Chartwell. “The additional safety checks throughout the process represents a new phase in operational excellence and patient safety. Omnicell’s expert staff coordinated with Chartwell every step of the way to make this possible.”
“Advanced IV compounding technology is a critical component to ensuring quality, accuracy, and standardization in producing dose-specific admixtures,” said Jeff Schlossnagle, Senior Vice President and Chief Growth Officer at Omnicell. “We’re proud to partner with CarepathRx and Chartwell to implement technology and intelligence solutions that are transforming pharmacy operations and delivering improved clinical and operational outcomes.”
About Chartwell Pennsylvania, LP
Chartwell Pennsylvania, LP, is a limited partnership between UPMC, Butler Health System, Heritage Valley Health System, and Washington Health System with three branch locations in Altoona, Erie, and Pittsburgh. CarepathRx, a national leader in pharmacy and medication management solutions, acquired the management services organization responsible for the operational and strategic management of Chartwell in 2020. For more than 30 years, Chartwell has provided the latest in advanced therapies and medications to patients for the treatment of chronic, rare, and/or complex conditions. The pharmacy provides services, therapies, and medications for home infusion, specialty pharmacy, and enteral nutrition throughout Pennsylvania, West Virginia, Ohio, New York, Florida, and South Carolina. www.chartwellpa.com
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.
Since 1992, Omnicell (Nasdaq:OMCL) has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.